• SENSEX 78,009.25
    -70.71 (--0.09%)
  • BANKNIFTY 57,491.10
    -144.15 (--0.25%)
  • ICICI Pru Life
    511.95 706.50(%)
  • HDFC Bank
    729.65 1,020.35(%)
  • Apollo Hospitals
    8,925.00 9,326.80(%)
  • Wework India
    700.00 419.60(%)
  • LG Electronics
    1,736.35 1,736.40(%)
  • Gland Pharma
    3,039.00 3,039.00(%)
  • Bharti Airtel
    2,005.65 2,174.70(%)
  • Leap India
    143.10 143.10(%)
  • Blue Star
    1,497.00 1,450.00(%)
  • Cupid
    288.00 32.76(%)
  • Netweb Technol.
    4,995.00 2,037.65(%)
  • Honasa Consumer
    509.90 509.90(%)
  • Manorama Indust.
    1,867.00 1,867.00(%)
  • Vodafone Idea
    14.17 15.35(%)
  • Technocraft Ven.
    334.60 334.60(%)
  • Bharat Dynamics
    1,420.00 1,655.25(%)
  • Dixon Technolog.
    14,210.00 18,471.50(%)
  • Billionbrains
    194.60 112.02(%)
  • Infosys
    1,159.00 984.00(%)
  • Gujarat Fluoroch
    4,897.00 4,959.45(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Medico Remedies Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 71781.0
  • ISIN : INE630Y01024
45.58 -2 (-4.76%)
  • As on 14 Aug 2026 (EOD)

  • Today’s Low

    43.63

  • Today’s High

    47.00

  • Open

    47.00

  • Perv Close

    47.86

  • 52W Low

    30.22

  • 52W High

    56.88

Key Indicators

  • P/E(TTM)

    28.49

  • Mar.Cap (₹Cr.)

    378.24

  • Div & Yield %

    0.00

  • Book Value(₹)

    9.10

  • Debt-Equity Ratio

    -4.76

  • AGM Date

    14-Aug-2026

  • EPS

    1.58

  • P/E Ratio

    28.49

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    378.24

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    16.60

  • BV (₹)

    9.10

  • Sales( ₹ in Cr.)

    206.38

  • NP (in Cr.)

    13.12

  • NP Var(%)

    30.0

  • Div%

    0.0

  • CPS (₹)

    2.00

  • EPS (₹)

    1.60

  • Traded Value (₹ in Lakhs)

    398.49

  • 52 Week High

    56.88

  • 52 Week Low

    30.22

  • Price BSE

    48.0

  • Price NSE

    48.00

  • Market Capital( in Cr.)

    398.49

  • P/C Ratio

    24.60

  • P/E Ratio

    30.40

  • Price Vs.BV

    1.60

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 150.94 144.92 140.44 121.02 122.39 88.64
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 150.94 144.92 140.44 121.02 122.39 88.64
Other Income 2.69 2.13 3.95 2.03 1.03 2.10
Stock Adjustments 5.16 -2.04 1.18 0.26 -1.54 3.63
Total Income 158.79 145.01 145.57 123.31 121.88 94.37
EXPENDITURE :            
Raw Materials 113.49 107.87 106.05 87.55 90.69 70.81
Power and Fuel Cost 2.92 2.55 2.47 2.29 1.91 1.83
Employee Cost 6.28 5.92 5.68 5.41 4.50 3.83
Other Manufacturing Expenses 7.72 6.25 5.48 6.44 5.25 4.56
Selling and Administration Expenses 10.84 6.49 11.92 11.20 10.60 7.72
Miscellaneous Expenses -0.15 0.89 0.40 1.05 2.66 0.68
Employee Benefit Expenses 6.28 5.92 5.68 5.41 4.50 3.83
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 141.10 129.97 132.00 113.95 115.61 89.42
Operating Profit 17.69 15.03 13.57 9.36 6.27 4.94
Interest 1.16 0.82 0.75 0.66 0.92 1.06
Gross Profit 16.53 14.21 12.82 8.70 5.35 3.88
Depreciation 3.03 2.88 2.72 2.22 1.65 1.66
Profit Before Tax 13.50 11.33 10.10 6.48 3.70 2.22
Current Tax 3.80 3.17 2.50 1.79 1.06 0.57
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.39 -0.12 0.36 -0.12 0.05 0.01
Reported Net Profit 10.09 8.29 7.24 4.81 2.59 1.63
Extraordinary Items 0.00 0.00 0.00 -0.03 0.00 0.00
Adjusted Net Profit 10.09 8.29 7.24 4.84 2.59 1.63
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 32.21 23.92 16.67 11.86 9.91 8.28
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 42.30 32.21 23.92 16.67 12.50 9.91
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 1.22 1.00 0.87 2.90 6.24 3.93
Earnings Per Share(Adj)-Unit Curr 1.22 1.00 0.87 0.58 0.31 0.20
Book Value 7.53 6.31 5.28 22.04 78.22 71.98
Book Value(Adj)-Unit Curr 7.53 6.31 5.28 4.41 3.91 3.60

Shareholding Pattern

  • Promoter Group

    61.38%

  • Public Share Holding

    38.62%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 50,937,145 61.38 50,937,145 6
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 50,937,145 61.38 50,937,145 6
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 64,722 0.08 64,722 2
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 64,722 0.08 64,722 2
2] Non Institution
Bodies Corporate 3,918,787 4.72 3,918,387 69
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 477,853 0.58 477,853 117
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 1,574,586 1.90 1,573,786 206
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 7,066,960 8.52 7,066,960 29
Individuals holding nominal share capital up to Rs. 1 lakh 12,579,636 15.16 12,578,036 15,430
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 5,664,309 6.83 5,664,309 1
Others 0 0.00 0 0
Sub Total 31,982,133 38.54 31,979,333 15,855
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 82,984,000 100.00 82,981,200 15,863

Company Background

Medico Remedies LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Medico Remedies Ltd
  • BSE Code : 71781.0
  • ISIN : INE630Y01024

  • Incorporation Year

    1994

  • Registered Office

    1105/1106 11-Flr Hubtown Solar
    N S Phadke Marg Andheri East, Mumbai,
    Maharashtra-400069

  • Telephone

    91-22-2670 1055/66

  • FAX

  • Chairman

    Haresh Mehta

  • Managing Director

  • Company Secretary

    Vidhi Ankit Shah

  • Auditor

    V J Shah & Co/Shah Shroff & Associates

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    Cameo Corporate Services Ltd
    Subramanian Building,
    1ST Floor No 1,Club House Road
    Mumbai - Chennai - 600002

Medico Remedies Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Medico Remedies 45.01 153.63 150.94 28.49 21.31
Abbott India 27,076.90 7,217.19 6,929.05 35.63 43.78
Astrazeneca Phar 7,753.70 2,304.07 2,275.58 114.28 27.86
Glaxosmi. Pharma 2,689.10 3,932.76 3,790.20 42.96 58.17
Novartis India 1,586.70 398.23 356.27 40.07 16.64
Cipla 1,450.00 20,102.60 18,979.95 38.11 13.88
Bliss GVS Pharma 524.05 773.53 729.81 48.66 12.51
Amrutanjan Healt 494.75 469.50 451.82 26.50 21.89
Fermenta Biotec. 449.40 474.15 450.25 20.98 18.77
Guj. Themis Bio. 349.05 152.47 150.80 78.09 27.21
Ambalal Sarabhai 42.47 19.52 3.94 78.65 6.77